HSUAX
Price
$41.48
Change
-$0.22 (-0.53%)
Updated
Sep 5 closing price
Net Assets
71.13M
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

HSUAX vs RGEBX

Header iconHSUAX vs RGEBX Comparison
Open Charts HSUAX vs RGEBXBanner chart's image
Rational Dynamic Brands A
Price$41.48
Change-$0.22 (-0.53%)
VolumeN/A
Net Assets71.13M
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
HSUAX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HSUAX vs. RGEBX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSUAX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. HSUAX (71.1M). HSUAX (0.00) and RGEBX (0.00) have matching dividends . HSUAX was incepted earlier than RGEBX: HSUAX (23 years) vs RGEBX (11 years). HSUAX (1.46) is less costly to investors than RGEBX (1.09). HSUAX is a more actively managed with annual turnover of: 340.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than HSUAX: RGEBX (250) vs HSUAX (1000). HSUAX (18.31) and RGEBX (17.59) have marching annual gain over last year. RGEBX return over 5 years is better than : 38.71 vs. HSUAX (7.16).
HSUAXRGEBXHSUAX / RGEBX
Total Expense Ratio1.461.09134%
Annual Report Gross Expense Ratio1.461.09134%
Fund Existence23 years11 years-
Gain YTD4.58915.39830%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets71.1M332B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year18.3117.59104%
Returns for 3 years62.9957.61109%
Returns for 5 years7.1638.7118%
Returns for 10 years-77.1091.44-84%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
ARCT17.851.09
+6.50%
Arcturus Therapeutics Holdings
MANH215.315.45
+2.60%
Manhattan Associates
TRMD23.020.25
+1.10%
TORM plc
INDP3.30-1.31
-28.35%
Indaptus Therapeutics Inc